Navigation Links
American Physiological Society endorses report on random source dogs and cats
Date:10/29/2009

BETHESDA, Md.The American Physiological Society (APS; www.the-aps.org) announced today that it has endorsed the recommendation of a National Academy of Sciences* (NAS) report calling for the identification of new suppliers to replace Class B dealers as providers of random source dogs and cats for medical research.

"Class B" is a broad category of licensure required by the United States Department of Agriculture (USDA) that applies to individuals who buy and sell animals that they do not breed and raise themselves. There are currently about a dozen Class B dealers who provide dogs and cats for medical and veterinary research and training and the development of veterinary drugs. The APS says that "immediate actions" are needed to identify or develop new suppliers of random source dogs and cats so that these activities may continue without disruption. A statement adopted by the APS Council on October 26, 2009 (http://www.the-aps.org/pa/resources/policyStmnts/paPolicyStmnts_dogscats.htm) underscores the importance of dogs and cats as research subjects: "These animals remain critical for health research to alleviate serious and life-threatening conditions that afflict humans and animals," the statement said.

Background

Most of the dogs and cats needed for research are specifically bred for that purpose, but some non-purpose bred or "random source" animals are also needed because these animals exhibit traits that are difficult to replicate in purpose-bred animals. Very old animals or ones with pre-existing health conditions, and exposure to viruses, allergens, or parasites may be needed to study age-related conditions or diseases that cannot be artificially induced. At one time local animal control facilities were willing to make such animals available for research, but nearly two dozen states and many municipalitiesincluding many where the affected research is being donenow have laws prohibiting that practice.

The APS statement points out that the NAS report, Scientific and Humane Issues in the Use of Random Source Dogs and Cats in Research, "found strong evidence of an ongoing need for random source dogs and cats in several important areas of biomedical research." At the same time, the NAS report also found evidence that a small number of USDA-licensed Class B dog and cat dealers had a history of recurrent Animal Welfare Act violations. The NAS panel, which was charged with examining the use of random source dogs and cats in research funded by the National Institutes of Health, recommended that NIH-funded researchers obtain random source dogs and cats from other suppliers. It offered as alternatives purchasing animals from commercial breeders (licensed by USDA as "Class A" dealers), animal control facilities, and hobby breeders. It also suggested that researchers obtain animals from individuals willing to donate them for research. However, the panel recognized that in some cases these alternate suppliers may be unable to provide the animals needed so it also suggested that "additional effort" by the NIH was needed to identify and/or develop new mechanisms to replace the animals currently supplied by Class B dealers.

Other needs for random source dogs and cats

The APS noted that the NAS panel had only focused on NIH-funded biomedical research and "did not address other needs for random source dogs and cats, such as the development and testing of animal health products and medical devices, medical research funded by entities other than the NIH, and medical and veterinary training." Consequently, the APS recommends that, "in addition to whatever steps NIH may take to meet the needs of its funded investigators, other provisions must be made to ensure that needs for random source dogs and cats in other fields can also be met."


'/>"/>

Contact: Alice Ra'anan
araanan@the-aps.org
301-634-7105
American Physiological Society
Source:Eurekalert

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Understanding hypertension in African Americans proves elusive
3. Tips from the Journals of the American Society for Microbiology
4. American Chemical Societys Weekly PressPac -- Aug. 15, 2007
5. American College of Medical Genetics responds to new FDA labeling decision for warfarin
6. American Chemical Societys Weekly Press Pac
7. Highlights from the September 2007 Journal of the American Dietetic Association
8. American Chemical Societys Weekly Presspac -- Aug. 29, 2007
9. Report: African, Asian, Latin American farm animals face extinction
10. American Chemical Society calls green chemistry bill a smart step
11. Challenges remain in reintroducing American chestnut
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)...  It sounds simple and harmless—an electronic sensor ... signs and alerts parents on their smart phones ... drops. But pediatric experts argue that such devices ... evidence of medical benefits, especially to healthy babies. ... parents of healthy babies, promising peace of mind ...
(Date:1/21/2017)... -- Research and Markets has announced the addition of ... their offering. ... The global voice recognition biometrics market to grow at a CAGR ... covers the present scenario and the growth prospects of the global ... the report considers the revenue generated from the sales of voice ...
(Date:1/19/2017)... , Jan. 19, 2017 Sensory ... experience and security for consumer electronics, and ... processing systems and cybersecurity solutions, today announced a ... and financial institutions worldwide to bolster security of ... end-to-end secure user authentication platforms they offer, innerCore ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... Baltimore, Maryland (PRWEB) , ... ... ... firm, PathSensors, Inc., announced today that in a published evaluation of multiple ... (PNNL), a U.S. Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection ...
(Date:2/23/2017)... ... ... The Greater Gift Initiative, Inc , (GGI) a Winston-Salem, NC 501(c)3 ... mission is to advance global health and highlight the greater good of clinical trial ... clinical trial volunteer. The vision of GGI is to serve as a philanthropic connector ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017 ... company, and Beyond Type 1, a not-for-profit advocacy and ... today announced a grant from Beyond Type 1 to ... type 1 and other insulin-requiring diabetes.  ... innovative stem cell-derived cell replacement therapies with a focus ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... is has acquired Kendall Research Systems, LLC (KRS) clinical development program. ... develops neural interface technology for research and clinical applications. The terms of the ...
Breaking Biology Technology: